| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-IL33 (109-266) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.05% Proclin300, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:1000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
Il33 |
| Gene ID: |
77125 |
| Uniprot ID: |
IL33_MOUSE |
| Immunogen Region: |
109-266 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 109-266 of mouse IL33 (NP_598536.2). |
| Immunogen Sequence: |
SIQGTSLLTQSPASLSTYND QSVSFVLENGCYVINVDDSG KDQEQDQVLLRYYESPCPAS QSGDGVDGKKLMVNMSPIKD TDIWLHANDKDYSVELQRGD VSPPEQAFFVLHKKSSDFVS FECKNLPGTYIGVKDNQLAL VEEKDESCNNIMFKLSKI |
| Post Translational Modifications | The full-length protein can be released from cells and is able to signal via the IL1RL1/ST2 receptor. However, proteolytic processing by CELA1, CSTG/cathepsin G and ELANE/neutrophil elastase produces C-terminal peptides that are more active than the unprocessed full-length protein. May also be proteolytically processed by calpains. Proteolytic cleavage mediated by apoptotic caspases including CASP3 and CASP7 results in IL33 inactivation. In vitro proteolytic cleavage by CASP1 was reported but could not be confirmed in vivo suggesting that IL33 is probably not a direct substrate for that caspase. |
| Function | Cytokine that binds to and signals through the IL1RL1/ST2 receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells. Involved in the maturation of Th2 cells inducing the secretion of T-helper type 2-associated cytokines. Also involved in activation of mast cells, basophils, eosinophils and natural killer cells. Acts as an enhancer of polarization of alternatively activated macrophages. Acts as a chemoattractant for Th2 cells, and may function as an 'alarmin', that amplifies immune responses during tissue injury. Induces rapid UCP2-dependent mitochondrial rewiring that attenuates the generation of reactive oxygen species and preserves the integrity of Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages. In quiescent endothelia the uncleaved form is constitutively and abundantly expressed, and acts as a chromatin-associated nuclear factor with transcriptional repressor properties, it may sequester nuclear NF-kappaB/RELA, lowering expression of its targets. This form is rapidely lost upon angiogenic or pro-inflammatory activation. |
| Protein Name | Interleukin-33Il-33 Cleaved Into - Interleukin-33(102-266 - Interleukin-33(109-266 |
| Database Links | Reactome: R-MMU-1257604Reactome: -MMU-5689880Reactome: -MMU-6811558Reactome: -MMU-9014843 |
| Cellular Localisation | NucleusChromosomeCytoplasmCytoplasmic VesicleSecretory VesicleSecretedSecreted And Released In The Extracellular Milieu By Passing Through The Gasdermin-D (Gsdmd) Pore Following Cleavage By Cela1Associates With Heterochromatin And Mitotic ChromosomesThe Secretion Is Dependent On Protein Unfolding And Facilitated By The Cargo Receptor Tmed10It Results In Protein Translocation From The Cytoplasm Into The Ergic (Endoplasmic Reticulum-Golgi Intermediate Compartment) Followed By Vesicle Entry And Secretion(Microbial Infection) Upon Infection With HPolygyrusTethered To The Nucleus By The HPolygyrus Parasitic Protein Ari |
| Alternative Antibody Names | Anti-Interleukin-33 antibodyAnti-Il-33 Cleaved Into - Interleukin-33(102-266 - Interleukin-33(109-266 antibodyAnti-Il33 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
